Review
Emtricitabine/tenofovir (Truvada) for HIV prophylaxis
Affiliations
- PMID: 24364575
Item in Clipboard
Review
Emtricitabine/tenofovir (Truvada) for HIV prophylaxis
Am Fam Physician.
.
Free article
No abstract available
Similar articles
-
HIV pre-exposure prophylaxis.BMJ. 2012 Aug 13;345:e5412. doi: 10.1136/bmj.e5412. BMJ. 2012. PMID: 22890030 No abstract available.
-
Preexposure prophylaxis: An emerging clinical approach to preventing HIV in high-risk adults.Nurse Pract. 2014 Sep 18;39(9):50-3. doi: 10.1097/01.NPR.0000452976.92052.fa. Nurse Pract. 2014. PMID: 25140852 Review.
-
Two-once-daily fixed-dose NRTI combinations for HIV.Med Lett Drugs Ther. 2005 Feb 28;47(1203):19-20. Med Lett Drugs Ther. 2005. PMID: 15767973
-
Transmission. Company halts Truvada PrEP for women study.AIDS Policy Law. 2011 Jun;26(7):1. AIDS Policy Law. 2011. PMID: 21735622 No abstract available.
-
Tenofovir: quo vadis anno 2012 (where is it going in the year 2012)?Med Res Rev. 2012 Jul;32(4):765-85. doi: 10.1002/med.21267. Epub 2012 May 11. Med Res Rev. 2012. PMID: 22581627 Review.
Cited by
-
Identifying Adverse Effects of HIV Drug Treatment and Associated Sentiments Using Twitter.JMIR Public Health Surveill. 2015 Jul 27;1(2):e7. doi: 10.2196/publichealth.4488. eCollection 2015 Jul-Dec. JMIR Public Health Surveill. 2015. PMID: 27227141 Free PMC article.
-
Protein and oligonucleotide delivery systems for vaginal microbicides against viral STIs.Cell Mol Life Sci. 2015 Feb;72(3):469-503. doi: 10.1007/s00018-014-1756-3. Epub 2014 Oct 17. Cell Mol Life Sci. 2015. PMID: 25323132 Free PMC article. Review.
-
Tenofovir-tethered gold nanoparticles as a novel multifunctional long-acting anti-HIV therapy to overcome deficient drug delivery-: an in vivo proof of concept.J Nanobiotechnology. 2023 Jan 19;21(1):19. doi: 10.1186/s12951-022-01750-w. J Nanobiotechnology. 2023. PMID: 36658575 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
